Clinical Variability of Family Members with the C104R Mutation in Transmembrane Activator and Calcium Modulator and Cyclophilin Ligand Interactor (TACI)
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Common Variable Immunodeficiency Disorder (CVID) is a complex disorder that predisposes patients to recurrent and severe infections. The C104R mutation in the transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) is the most frequent mutation identified in patients with CVID. We carried out a detailed immunological and molecular study in a family with a C104R mutation.
We have undertaken segregation analysis of a kindred with C104R mutations of the TACI gene. Detailed immunological and molecular investigations were carried out for this kindred and the clinical phenotype was compared to the genotype.
Segregation analysis of our kindred showed that inheriting single or double copy of the C104R mutation does not consign an individual to CVID. All heterozygotes in the family were phenotypically different, ranging from asymptomatic to ill-health. A family member with a wild type TACI variant had CVID-related phenotype including IgA deficiency and type 1 diabetes. Interestingly, a family member with the homozygous C104R/C104R variant did not meet the criteria for CVID because he had excellent, albeit unsustained, vaccine responses to T cell dependent and T cell independent vaccine antigens despite profound hypogammaglobulinemia.
The C104R mutation does not correlate with the clinical phenotypes in this family.
- Conley, ME, Notarangelo, LD, Etzioni, A (1999) Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93: pp. 190-197 CrossRef
- Oksenhendler, E, Gerard, L, Fieschi, C, Malphettes, M, Mouillot, G, Jaussaud, R (2008) Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 46: pp. 1547-1554 CrossRef
- Ameratunga, R, Becroft, DM, Hunter, W (2000) The simultaneous presentation of sarcoidosis and common variable immune deficiency. Pathology 32: pp. 280-282
- Castigli, E, Geha, RS (2006) Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol 117: pp. 740-746 CrossRef
- Bacchelli, C, Buckridge, S, Thrasher, AJ, Gaspar, HB (2007) Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency. Clin Exp Immunol 149: pp. 401-409 CrossRef
- Finck, A, Meer, JW, Schaffer, AA, Pfannstiel, J, Fieschi, C, Plebani, A (2006) Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q. Eur J Hum Genet 14: pp. 867-875 CrossRef
- Salzer U, Gutenberger S, Bossaller L, Schlesier M, Grimbacher B, Eibel H, et al., editors. Finally found: human BAFF-R deficiency causes CVID. XIth Meeting of the European Society for Immunodeficiencies; 2004 21–24 October; Versailles.
- Salzer, U, Chapel, HM, Webster, AD, Pan-Hammarstrom, Q, Schmitt-Graeff, A, Schlesier, M (2005) Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37: pp. 820-828 CrossRef
- Castigli, E, Wilson, SA, Garibyan, L, Rachid, R, Bonilla, F, Schneider, L (2005) TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37: pp. 829-834 CrossRef
- Volanakis, JE, Zhu, ZB, Schaffer, FM, Macon, KJ, Palermos, J, Barger, BO (1992) Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J Clin Investig 89(: pp. 1914-1922 CrossRef
- Olerup, O, Smith, CI, Bjorkander, J, Hammarstrom, L (1992) Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc Natl Acad Sci U S A 89: pp. 10653-10657 CrossRef
- Grimbacher, B, Hutloff, A, Schlesier, M, Glocker, E, Warnatz, K, Drager, R (2003) Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4: pp. 261-268 CrossRef
- Zelm, MC, Smet, J, Adams, B, Mascart, F, Schandene, L, Janssen, F (2010) CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Investig 120: pp. 1265-1274 CrossRef
- Zelm, MC, Reisli, I, Burg, M, Castano, D, Noesel, CJ, Tol, MJ (2006) An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 354: pp. 1901-1912 CrossRef
- Kuijpers, TW, Bende, RJ, Baars, PA, Grummels, A, Derks, IA, Dolman, KM (2010) CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Investig 120: pp. 214-222 CrossRef
- Thiel J, Kimmig L, Salzer U, Grudzien M, Lebrecht D, Hagena T, et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol. 2012;129(3):801–10.e6.
- Garibyan, L, Lobito, AA, Siegel, RM, Call, ME, Wucherpfennig, KW, Geha, RS (2007) Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). J Clin Investig 117: pp. 1550-1557 CrossRef
- Poodt, AE, Driessen, GJ, Klein, A, Dongen, JJ, Burg, M, Vries, E (2009) TACI mutations and disease susceptibility in patients with common variable immunodeficiency. Clin Exp Immunol 156: pp. 35-39 CrossRef
- Salzer, U, Bacchelli, C, Buckridge, S, Pan-Hammarstrom, Q, Jennings, S, Lougaris, V (2009) Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 113: pp. 1967-1976 CrossRef
- Detkova, D, Martinez-Pomar, N, Arostegui, J, Escobar, D, Ferrer, J, Serra, A (2008) Role of the p.C104R variant of TNFRSF13B encoding TACI in patients with common variable immunodeficiency (CVID). Clin Exp Immunol 150: pp. 158
- Pan-Hammarstrom, Q, Salzer, U, Du, L, Bjorkander, J, Cunningham-Rundles, C, Nelson, DL (2007) Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 39: pp. 429-430 CrossRef
- Mohammadi J, Liu C, Aghamohammadi A, Bergbreiter A, Du L, Lu J, et al. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. J Clin Immunol. 2009 Jul 23.
- Speletas M, Mamara A, Papadopoulou-Alataki E, Iordanakis G, Liadaki K, Bardaka F, et al. TNFRSF13B/TACI alterations in greek patients with antibody deficiencies. J Clin Immunol. 2011 May 6.
- Ameratunga, R, Woon, ST, Neas, K, Love, DR (2010) The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review. Allergy Asthma Clin Immunol. 6: pp. 12 CrossRef
- Ferry, BL, Jones, J, Bateman, EA, Woodham, N, Warnatz, K, Schlesier, M (2005) Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method. Clin Exp Immunol 140: pp. 532-539 CrossRef
- Wehr, C, Kivioja, T, Schmitt, C, Ferry, B, Witte, T, Eren, E (2008) The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111: pp. 77-85 CrossRef
- Ameratunga, R, Lederman, HM, Sullivan, KE, Ochs, HD, Seyama, K, French, JK (1997) Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J Pediatr 131: pp. 147-150
- Arnett, FC, Edworthy, SM, Bloch, DA, McShane, DJ, Fries, JF, Cooper, NS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: pp. 315-324 CrossRef
- Salzer, U, Birmelin, J, Bacchelli, C, Witte, T, Buchegger-Podbielski, U, Buckridge, S (2007) Sequence analysis of TNFRSF13b, encoding TACI, in patients with systemic lupus erythematosus. J Clin Immunol 27: pp. 372-377 CrossRef
- Sarantopoulos, A, Tselios, K, Skendros, P, Bougiouklis, D, Theodorou, I, Boura, P (2008) Genetic polymorphism study of regulatory B cell molecules and cellular immunity function in an adult patient with common variable immunodeficiency. Hippokratia. 12: pp. 188-190
- Bacchelli, C, Buckland, KF, Buckridge, S, Salzer, U, Schneider, P, Thrasher, AJ (2011) The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice. J Allergy Clin Immunol 127: pp. 1253 e13-1259 e13 CrossRef
- Thierry-Carstensen B, Jordan K, Uhlving HH, Dalby T, Sorensen C, Jensen AM, et al. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults. Vaccine. 2012;30(37):5464–71.
- Wernette, CM, Frasch, CE, Madore, D, Carlone, G, Goldblatt, D, Plikaytis, B (2003) Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol 10: pp. 514-519
- Ameratunga, SN, Lennon, DR, Entwistle, B, Robinson, E, Ameratunga, RV (1997) The immunogenicity of Haemophilus influenzae: meningococcal protein conjugate vaccine in Polynesian and non-Polynesian New Zealand infants. J Paediatr Child Health. 33: pp. 138-141 CrossRef
- Lee, JJ, Jabara, HH, Garibyan, L, Rauter, I, Sannikova, T, Dillon, SR (2010) The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. J Allergy Clin Immunol 126: pp. 1234 e2-1241 e2 CrossRef
- Wehr, C, Eibel, H, Masilamani, M, Illges, H, Schlesier, M, Peter, HH (2004) A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol 113: pp. 161-171 CrossRef
- Warnatz, K, Wehr, C, Drager, R, Schmidt, S, Eibel, H, Schlesier, M (2002) Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology 206: pp. 502-513 CrossRef
- Clinical Variability of Family Members with the C104R Mutation in Transmembrane Activator and Calcium Modulator and Cyclophilin Ligand Interactor (TACI)
Journal of Clinical Immunology
Volume 33, Issue 1 , pp 68-73
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- C104R mutation
- Industry Sectors
- Author Affiliations
- 1. Department of Virology and Immunology, Auckland City Hospital, Park Rd, Auckland, New Zealand
- 2. Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
- 3. Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand
- 4. School of Biological Sciences, University of Auckland, Auckland, New Zealand
- 5. Department of Clinical Immunology, Auckland City Hospital, Park Rd, Auckland, New Zealand